RecensMedical

RecensMedical is a South Korean company specializing in advanced healthcare solutions, focusing on innovative medical technology and treatment options aimed at enhancing patient care and clinical outcomes. Founded in 2016 and headquartered in Ulsan, South Korea, RecensMedical focuses on developing medical devices and diagnostic tools. The company was co-founded by Gun-Ho Kim and Peter Kang, who have a history of engagement in the healthcare sector. In March 2022, RecensMedical raised KRW 35 billion in venture funding from investors including BNK Securities, KB Securities, LB Investment, and STIC Ventures, marking its third deal to date, with total funding raised amounting to KRW 35 billion.

RecensMedical specializes in providing advanced healthcare solutions centered around medical technology and innovative treatment options. The company’s core products encompass a range of medical devices and diagnostic tools designed to enhance patient care and improve clinical outcomes, specifically targeting challenges such as chronic disease management and surgical precision. Their products are primarily utilized by hospitals, clinics, and healthcare practitioners across various markets, particularly in regions with a high demand for medical innovations. In the most recent fiscal year of 2023, RecensMedical reported a revenue of KRW 4,208,597.

30. RecensMedical plans to utilize the KRW 35 billion raised in its most recent funding round to support the development of new products and expand into new geographic markets. The company is focused on launching additional medical devices designed to address emerging healthcare needs. Specific regions targeted for expansion include Southeast Asia and the Middle East by the end of 2024, enabling RecensMedical to tap into growing markets with increasing demand for advanced healthcare solutions.